Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)
Objective: This study aims to analyze the visual cognition profile of asymptomatic and symptomatic carriers of Huntington's disease (HD), compared with healthy controls (HC), and…HD Constellation: A novel patient-centred approach to enriching clinical datasets by combining medical record chart review and Enroll-HD
Objective: HD Constellation aims to create a dataset providing a longitudinal view of the Huntington’s disease (HD) course, based on physician-provided medical records in the…Biological and Clinical Manifestations of Huntington’s disease in Gene Carriers Very Far from Predicted Onset: The Young Adult Study
Objective: To perform a deep phenotyping of a Huntington’s Disease (HD) cohort further from onset than previously studied to establish when disease related markers first…Longitudinal Utility of the Montreal Cognitive Assessment and Mini Mental State Exam in Huntington’s disease (HD)
Objective: Neuropsychological assessments are useful tools for examining and tracking cognitive impairment in individuals with neurological disorders; however, a full neuropsychological battery is not realistic…Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease
Objective: To identify when white matter connections first begin to degenerate in HD and which connections are most susceptible to early degeneration. Background: Huntington’s disease…Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population
Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…7 Tesla MRI investigation of cortical thickness in patients with Huntington’s disease and age-matched healthy controls
Objective: Evaluate cortical thickness in Huntington's disease (HD) using 7 Tesla (T) MRI. Background: There are currently no effective disease-modifying therapies for HD. In order…Modelling Huntington’s disease diagnosed prevalence from diagnosed incidence and survival time
Objective: To develop an epidemiological model of manifest Huntington’s disease (HD) to estimate international HD diagnosed prevalence by Shoulson–Fahn Total Functional Capacity (TFC)-based Stage based…Apathy as a non-motor symptom(NMS) in patients with Parkinson’s disease(PwPD) and patients with Huntington’s disease(PwHD) in Tomsk, Russia
Objective: The aim is to evaluate and compare the apathy profile in PwHD and PwPD, using the same clinical criteria to assess the severity of…Huntington’s disease in Egypt; A big challenge for a mysterious disease
Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 20
- Next Page »